Experienced in Rhizomelic Pseudopolyarthritis

Adeline Witrand-Ruyssen

Toulouse, FR 
Experienced in Rhizomelic Pseudopolyarthritis
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Adeline Witrand-Ruyssen practices in Toulouse, France. Ms. Witrand-Ruyssen is rated as an Experienced expert by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Arthritis, Axial Spondyloarthritis (AxSpA), Rheumatoid Arthritis (RA), and Psoriatic Arthritis.

Her clinical research consists of co-authoring 106 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Rhizomelic Pseudopolyarthritis.

Gender
Female

Locations

Toulouse, France
Other Locations
Rouen, France
Dinan, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of 12 Months Subcutaneous Tocilizumab in Rheumatoid Arthritis Phase IV Prospective Multicentrique Study
Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of 12 Months Subcutaneous Tocilizumab in Rheumatoid Arthritis Phase IV Prospective Multicentrique Study
Enrollment Status: Completed
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drug: Subcutaneous tocilizumab
Study Phase: Phase 4
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Enrollment Status: Completed
Publish Date: July 16, 2024
Intervention Type: Drug
Study Drugs: NSAIDs, anti-TNF
Study Phase: Phase 3
Randomized Placebo-controlled Trial Comparing Methotrexate vs. Methotrexate/Metformin Association in Rheumatoid Arthritis Patients
Randomized Placebo-controlled Trial Comparing Methotrexate vs. Methotrexate/Metformin Association in Rheumatoid Arthritis Patients
Enrollment Status: Active_not_recruiting
Publish Date: June 21, 2024
Intervention Type: Other, Drug
Study Drugs: Metformin, Methotrexate
Study Phase: Phase 2
Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T
Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Device
Bone MicroArchitecture Abatacept in Rheumatoid Arthritis Patients (BMA2)
Bone MicroArchitecture Abatacept in Rheumatoid Arthritis Patients (BMA2)
Enrollment Status: Terminated
Publish Date: July 24, 2020
Intervention Type: Other
Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients
Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients
Enrollment Status: Completed
Publish Date: June 22, 2020
Intervention Type: Behavioral
Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
Enrollment Status: Completed
Publish Date: September 27, 2019
Intervention Type: Other
View 6 Less Clinical Trials

106 Total Publications

Effect of intra-articular adipose-derived mesenchymal stromal cell versus placebo injection on pain and function in patients with knee osteoarthritis: the ADIPOA2 phase 2b randomised clinical trial.
Effect of intra-articular adipose-derived mesenchymal stromal cell versus placebo injection on pain and function in patients with knee osteoarthritis: the ADIPOA2 phase 2b randomised clinical trial.
Journal: Annals of the rheumatic diseases
Published: May 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Witrand-Ruyssen's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile